We are pleased to share that we will be attending the 33rd Medicinal Chemistry meeting by the Royal Society of Chemistry on 28th April, 2022 at Hatfield, United Kingdom.
The 33rd Medicinal Chemistry meeting will comprise presentations showcasing medicinal chemistry case studies from tools to candidates, across a range of modalities, therapeutic areas and target classes, as well as covering more general topics from the forefront of drug discovery of relevance to medicinal chemist. This meeting is regularly attended by scientists including chemists, biophysicists, structural biologists, research scholars, etc., with the aim to discuss the latest tools & processes in medicinal chemistry across all major target classes and therapeutic areas.
Visit – https://www.rscbmcs.org/events/mcee/
o2h discovery is a Contract Research Organization which has an integrated drug discovery platform operating from our state-of-the-art research center in India and The Mill SciTech Park, Cambridge, UK. We have the in-house capability to execute hit-lead-optimization programs leading into patent and IND filing from our state-of-the-art biotechnology incubator with expertise in discovery chemistry, biology, pharmacology, and the ongoing project management of pre-clinical development.